|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yuan W, Xiaoyun H, Haifeng Q, Jing L,
Weixu H, Ruofan D, Jinjin Y and Zongji S: MicroRNA-218 enhances the
radiosensitivity of human cervical cancer via promoting radiation
induced apoptosis. Int J Med Sci. 11:691–696. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pareja R, Rendon GJ, Sanz-Lomana CM,
Monzon O and Ramirez PT: Surgical, oncological, and obstetrical
outcomes after abdominal radical trachelectomy - a systematic
literature review. Gynecol Oncol. 131:77–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith RA, Brooks D, Cokkinides V, Saslow D
and Brawley OW: Cancer screening in the united states, 2013: A
review of current american cancer society guidelines, current
issues in cancer screening, and new guidance on cervical cancer
screening and lung cancer screening. CA Cancer J Clin. 63:88–105.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Waggoner SE: Cervical cancer. Lancet.
361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y and Srivastava D: A developmental
view of microRNA function. Trends Biochem Sci. 32:189–197. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu Y, Xie H, Liu Y, Liu W, Liu M and Tang
H: miR-484 suppresses proliferation and epithelial-mesenchymal
transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
Cancer Cell Int. 17:362017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhong J, Huang R, Su Z, Zhang M, Xu M,
Gong J, Chen N, Zeng H, Chen X and Zhou Q: Downregulation of
miR-199a-5p promotes prostate adeno-carcinoma progression through
loss of its inhibition of HIF-1α. Oncotarget. 8:83523–83538. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Jin Y, Zhang H, Huang X, Zhang Y
and Zhu J: MicroRNA-599 inhibits metastasis and
epithelial-mesenchymal transition via targeting EIF5A2 in gastric
cancer. Biomed Pharmacother. 97:473–480. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Liu Z, Fang X and Yang H:
MiR-142-5p suppresses tumorigenesis by targeting PIK3CA in
non-small cell lung cancer. Cell Physiol Biochem. 43:2505–2515.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Subramanian S, Lui WO, Lee CH, Espinosa I,
Nielsen TO, Heinrich MC, Corless CL, Fire AZ and van de Rijn M:
MicroRNA expression signature of human sarcomas. Oncogene.
27:2015–2026. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Banno K, Iida M, Yanokura M, Kisu I, Iwata
T, Tominaga E, Tanaka K and Aoki D: MicroRNA in cervical cancer:
OncomiRs and tumor suppressor miRs in diagnosis and treatment.
ScientificWorldJournal. 2014:1780752014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mao K, Lei D, Zhang H and You C:
MicroRNA-485 inhibits malignant biological behaviour of
glioblastoma cells by directly targeting PAK4. Int J Oncol.
51:1521–1532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang
HY and Wu SX: Low serum level of miR-485-3p predicts poor survival
in patients with glioblastoma. PLoS One. 12:e01849692017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jing LL and Mo XM: Reduced miR-485-5p
expression predicts poor prognosis in patients with gastric cancer.
Eur Rev Med Pharmacol Sci. 20:1516–1520. 2016.PubMed/NCBI
|
|
21
|
Mou X and Liu S: MiR-485 inhibits
metastasis and EMT of lung adenocarcinoma by targeting Flot2.
Biochem Biophys Res Commun. 477:521–526. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo L, Lu W, Zhang X, Luo D and Zhang H:
Metastasis-associated colon cancer-1 is a novel prognostic marker
for cervical cancer. Int J Clin Exp Pathol. 7:4150–4155.
2014.PubMed/NCBI
|
|
24
|
Zhou X, Xu CJ, Wang JX, Dai T, Ye YP, Cui
YM, Liao WT, Wu XL and Ou JP: Metastasis-associated in colon
cancer-1 associates with poor prognosis and promotes cell invasion
and angiogenesis in human cervical cancer. Int J Gynecol Cancer.
25:1353–1363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hua F, Xia Y, Wang H, Chen R, Ren Y, Yang
J and Liang W: Effects of small interfering RNA silencing MACC-1
expression on cell proliferation, cell cycle and invasion ability
of cervical cancer SiHa cells. Zhonghua Zhong Liu Za Zhi.
36:496–500. 2014.(In Chinese). PubMed/NCBI
|
|
26
|
Chen XP, Ren XP, Lan JY, Chen YG and Shen
ZJ: Analysis of HGF, MACC1, C-met and apoptosis-related genes in
cervical carcinoma mice. Mol Biol Rep. 41:1247–1256. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chai H and Yang Y: Effects of MACC1 siRNA
on biological behaviors of HeLa. Arch Gynecol Obstet.
289:1271–1280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma
H, Xia J, Bin J, Liao Y and Liao W: MiR-338-3p inhibits
epithelial-mesenchymal transition in gastric cancer cells by
targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget.
6:15222–15234. 2015.PubMed/NCBI
|
|
29
|
Yao Y, Dou C, Lu Z, Zheng X and Liu Q:
MACC1 suppresses cell apoptosis in hepatocellular carcinoma by
targeting the HGF/c-MET/AKT pathway. Cell Physiol Biochem.
35:983–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang P, Xi J and Liu S: MiR-139-3p
induces cell apoptosis and inhibits metastasis of cervical cancer
by targeting NOB1. Biomed Pharmacother. 83:850–856. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dong P, Xiong Y, Watari H, Hanley SJ,
Konno Y, Ihira K, Suzuki F, Yamada T, Kudo M, Yue J and Sakuragi N:
Suppression of iASPP-dependent aggressiveness in cervical cancer
through reversal of methylation silencing of microRNA-124. Sci Rep.
6:354802016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng F, Zhang J, Luo S, Yi J, Wang P,
Zheng Q and Wen Y: miR-143 is associated with proliferation and
apoptosis involving ERK5 in HeLa cells. Oncol Lett. 12:3021–3027.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo GX, Li QY, Ma WL, Shi ZH and Ren XQ:
MicroRNA-485-5p suppresses cell proliferation and invasion in
hepatocellular carcinoma by targeting stanniocalcin 2. Int J Clin
Exp Pathol. 8:12292–12299. 2015.PubMed/NCBI
|
|
34
|
Sun X, Liu Y, Li M, Wang M and Wang Y:
Involvement of miR-485-5p in hepatocellular carcinoma progression
targeting EMMPRIN. Biomed Pharmacother. 72:58–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen Z, Li Q, Wang S and Zhang J: miR4855p
inhibits bladder cancer metastasis by targeting HMGA2. Int J Mol
Med. 36:1136–1142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lou C, Xiao M, Cheng S, Lu X, Jia S, Ren Y
and Li Z: MiR-485-3p and miR-485-5p suppress breast cancer cell
metastasis by inhibiting PGC-1α expression. Cell Death Dis.
7:e21592016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Anaya-Ruiz M, Bandala C and Perez-Santos
JL: miR-485 acts as a tumor suppressor by inhibiting cell growth
and migration in breast carcinoma T47D cells. Asian Pac J Cancer
Prev. 14:3757–3760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu J, Li J, Ren J and Zhang D:
MicroRNA-485-5p represses melanoma cell invasion and proliferation
by suppressing Frizzled7. Biomed Pharmacother. 90:303–310. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin XJ, He CL, Sun T, Duan XJ, Sun Y and
Xiong SJ: Hsa-miR-485-5p reverses epithelial to mesenchymal
transition and promotes cisplatin-induced cell death by targeting
PAK1 in oral tongue squamous cell carcinoma. Int J Mol Med.
40:83–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu J, Wu SW and Wu WP: A tumor-suppressive
microRNA, miRNA-485-5p, inhibits glioma cell proliferation and
invasion by down-regulating TPD52L2. Am J Transl Res. 9:3336–3344.
2017.PubMed/NCBI
|
|
41
|
Kang M, Ren MP, Zhao L, Li CP and Deng MM:
miR-485-5p acts as a negative regulator in gastric cancer
progression by targeting flotillin-1. Am J Transl Res. 7:2212–2222.
2015.PubMed/NCBI
|
|
42
|
Duan J, Zhang H, Li S, Wang X, Yang H,
Jiao S and Ba Y: The role of miR-485-5p/NUDT1 axis in gastric
cancer. Cancer Cell Int. 17:922017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Koh YW, Hur H and Lee D: Increased MACC1
expression indicates a poor prognosis independent of MET expression
in gastric adenocarcinoma. Pathol Res Pract. 212:93–100. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tang J, Chen JX, Chen L, Tang JY, Cui Z,
Liu CH and Wang Z: Metastasis associated in colon cancer 1 (MACC1)
promotes growth and metastasis processes of colon cancer cells. Eur
Rev Med Pharmacol Sci. 20:2825–2834. 2016.PubMed/NCBI
|
|
45
|
Sun DW, Zhang YY, Qi Y, Liu GQ, Chen YG,
Ma J and Lv GY: Prognostic and clinicopathological significance of
MACC1 expression in hepatocellular carcinoma patients: A
meta-analysis. Int J Clin Exp Med. 8:4769–4777. 2015.PubMed/NCBI
|
|
46
|
Yang T, Kong B, Kuang YQ, Cheng L, Gu JW,
Zhang JH, Shu HF, Yu SX, He WQ, Xing XM and Huang HD:
Overexpression of MACC1 protein and its clinical implications in
patients with glioma. Tumour Biol. 35:815–819. 2014. View Article : Google Scholar : PubMed/NCBI
|
